Genome-Wide CRISPR-Cas9 Screening Identifies a Synergy between Hypomethylating Agents and SUMOylation Blockade in Myelodysplastic Syndromes and Acute Myeloid Leukemia
RNA-seq (gene expression) · human · 18 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Myelodysplastic syndromesThis series is part of our curated briefing on it.
- Samples
- 18 samples: 7 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cellsNature communications · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE261339_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1086510 and SRA study SRP494593. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 18 samples.
How we read this: 7 replicated groups read from 18 sample titles; they account for 18 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8140751 MDSL-Cas9-sgROSA, D4, DMSO, Rp1 MDSL-Cas9-sgROSA, D4, D…
- GSM8140752 MDSL-Cas9-sgROSA, D4, DMSO, Rp2 MDSL-Cas9-sgROSA, D4, D…
- GSM8140753 MDSL-Cas9-sgROSA, D4, DMSO, Rp3 MDSL-Cas9-sgROSA, D4, D…
- GSM8140754 MDSL-Cas9-sgROSA, D4, AZA , Rp1 MDSL-Cas9-sgROSA, D4, A…
- GSM8140755 MDSL-Cas9-sgROSA, D4, AZA , Rp2 MDSL-Cas9-sgROSA, D4, A…
- GSM8140756 MDSL-Cas9-sgROSA, D4, AZA , Rp3 MDSL-Cas9-sgROSA, D4, A…
- GSM8140757 MDSL-Cas9-sgTOPORS, D4, DMSO, Rp1 MDSL-Cas9-sgTOPORS, D4,…
- GSM8140758 MDSL-Cas9-sgTOPORS, D4, DMSO, Rp2 MDSL-Cas9-sgTOPORS, D4,…
- GSM8140759 MDSL-Cas9-sgTOPORS, D4, DMSO, Rp3 MDSL-Cas9-sgTOPORS, D4,…
- GSM8140760 MDSL-Cas9-sgTOPORS, D4, AZA, Rp1 MDSL-Cas9-sgTOPORS, D4,…
- GSM8140761 MDSL-Cas9-sgTOPORS, D4, AZA, Rp2 MDSL-Cas9-sgTOPORS, D4,…
- GSM8140762 MDSL-Cas9-sgTOPORS, D4, AZA, Rp3 MDSL-Cas9-sgTOPORS, D4,…
- GSM8140763 MDSL-Cas9, BRUNELLO, T0, Untreated, Rp1 MDSL-Cas9, BRUNELLO, T0…
- GSM8140764 MDSL-Cas9, BRUNELLO, T0, Untreated, Rp2 MDSL-Cas9, BRUNELLO, T0…
- GSM8140765 MDSL-Cas9, BRUNELLO, T19, DMSO, Rp1 MDSL-Cas9, BRUNELLO, T1…
- GSM8140766 MDSL-Cas9, BRUNELLO, T19, DMSO, Rp2 MDSL-Cas9, BRUNELLO, T1…
- GSM8140767 MDSL-Cas9, BRUNELLO, T19, AZA, Rp1 MDSL-Cas9, BRUNELLO, T1…
- GSM8140768 MDSL-Cas9, BRUNELLO, T19, AZA, Rp2 MDSL-Cas9, BRUNELLO, T1…
- GSE129828 DNA Methylation Identifies Genetically and Prognostically Distinct Subtypes of Myelodysplastic Syndromes 141 samples same disease briefing · shares myelodysplastic, identifies, syndromes
- GSE256396 Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower risk myelodysplastic syndromes 374 samples same disease briefing · shares myelodysplastic, syndromes
- GSE15688 Acquired mutations in TET2 are common in myelodysplastic syndromes 122 samples same disease briefing · shares myelodysplastic, syndromes
- GSE31174 Affymetrix SNP array data for myelodysplastic syndromes (MDS) and related neoplasms 58 samples same disease briefing · shares myelodysplastic, syndromes
- GSE211032 Expression Analysis (RNA-Seq) of adult Myelodysplastic Syndromes (MDS)/Acute Myeloid Leukemia (AML) with isolated monosomy 7 compared to controls 45 samples same disease briefing · shares myelodysplastic, syndromes
- GSE272173 Molecular profiling of pre-and post-5-azacytidine myelodysplastic syndrome samples identifies predictors of response 34 samples same disease briefing · shares myelodysplastic, identifies
- GSE292039 Splicing of erythroid transcription factor is associated with therapeutic response in myelodysplastic syndromes 27 samples same disease briefing · shares myelodysplastic, syndromes
- GSE237148 Targeting IL-1b–mediated inflammatory signaling overcomes transfusion dependence in early-stage myelodysplastic syndromes 26 samples same disease briefing · shares myelodysplastic, syndromes
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.